INR 98.3
(2.41%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 41.77 Million INR | -22.35% |
2022 | 53.79 Million INR | 14.14% |
2021 | 47.12 Million INR | 57.26% |
2020 | 29.96 Million INR | 2.74% |
2019 | 29.16 Million INR | -32.08% |
2018 | 42.94 Million INR | 5.57% |
2017 | 40.67 Million INR | 1.97% |
2016 | 39.88 Million INR | -33.25% |
2015 | 59.76 Million INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2024 Q2 | 49.34 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 Q4 | 41.77 Million INR | 0.0% |
2023 FY | 41.77 Million INR | -22.35% |
2023 Q2 | 41.73 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2022 FY | 53.79 Million INR | 14.14% |
2022 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 53.79 Million INR | 0.0% |
2022 Q2 | 45.3 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 FY | 47.12 Million INR | 57.26% |
2021 Q4 | 47.12 Million INR | 0.0% |
2021 Q2 | 29.89 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2020 FY | 29.96 Million INR | 2.74% |
2020 Q2 | 26.1 Million INR | 0.0% |
2020 Q4 | 29.96 Million INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2019 FY | 29.16 Million INR | -32.08% |
2019 Q1 | 31.33 Million INR | -27.03% |
2019 Q4 | 29.16 Million INR | -16.44% |
2019 Q2 | 31.33 Million INR | 0.0% |
2019 Q3 | 34.9 Million INR | 11.4% |
2018 FY | 42.94 Million INR | 5.57% |
2018 Q3 | 48.94 Million INR | 11.76% |
2018 Q4 | 42.94 Million INR | -12.26% |
2018 Q2 | 43.79 Million INR | 0.0% |
2018 Q1 | 43.79 Million INR | 0.0% |
2017 FY | 40.67 Million INR | 1.97% |
2016 FY | 39.88 Million INR | -33.25% |
2015 FY | 59.76 Million INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Hester Biosciences Limited | 755.81 Million INR | 94.473% |
RPG Life Sciences Limited | 1.01 Billion INR | 95.864% |
Suven Pharmaceuticals Limited | 2.31 Billion INR | 98.193% |
Ipca Laboratories Limited | 24.71 Billion INR | 99.831% |
Aarti Drugs Limited | 4.85 Billion INR | 99.14% |
Aarti Pharmalabs Limited | 6.42 Billion INR | 99.35% |
Albert David Limited | 436.12 Million INR | 90.422% |
Alembic Limited | 113.4 Million INR | 63.166% |
Alkem Laboratories Limited | 26.61 Billion INR | 99.843% |
Alembic Pharmaceuticals Limited | 16.43 Billion INR | 99.746% |
Bafna Pharmaceuticals Limited | 296.41 Million INR | 85.908% |
Bajaj HealthCare Limited | 1.44 Billion INR | 97.1% |
Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -63.823% |
Brooks Laboratories Limited | 96.1 Million INR | 56.538% |
Eris Lifesciences Limited | 1.89 Billion INR | 97.79% |
FDC Limited | 3.88 Billion INR | 98.926% |
Glenmark Life Sciences Limited | 6.66 Billion INR | 99.373% |
Gufic Biosciences Limited | 2 Billion INR | 97.917% |
Hikal Limited | 3.03 Billion INR | 98.625% |
Ind-Swift Laboratories Limited | 104.57 Million INR | 60.058% |
Ind-Swift Limited | 640.91 Million INR | 93.483% |
Innova Captab Limited | 1.44 Billion INR | 97.1% |
IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 99.017% |
Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | 72.148% |
Jubilant Pharmova Limited | 12.89 Billion INR | 99.676% |
Kilitch Drugs (India) Limited | 39.88 Million INR | -4.739% |
Laurus Labs Limited | 18.45 Billion INR | 99.774% |
Lincoln Pharmaceuticals Limited | 771.68 Million INR | 94.587% |
Lupin Limited | 49.53 Billion INR | 99.916% |
Mangalam Drugs & Organics Limited | 1.23 Billion INR | 96.622% |
Medico Remedies Limited | 163.37 Million INR | 74.433% |
Morepen Laboratories Limited | 2.48 Billion INR | 98.32% |
Nectar Lifesciences Limited | 7.09 Billion INR | 99.411% |
Orchid Pharma Limited | 2.64 Billion INR | 98.419% |
Procter & Gamble Health Limited | 1.09 Billion INR | 96.172% |
Sigachi Industries Limited | 707.2 Million INR | 94.094% |
Solara Active Pharma Sciences Limited | 3.59 Billion INR | 98.839% |
Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.958% |
Themis Medicare Limited | 705.74 Million INR | 94.081% |
Unichem Laboratories Limited | 7.04 Billion INR | 99.407% |
Vaishali Pharma Limited | 3.79 Million INR | -1000.079% |
Venus Remedies Limited | 1.21 Billion INR | 96.568% |
Wanbury Limited | 360.23 Million INR | 88.405% |
Windlas Biotech Limited | 621.89 Million INR | 93.283% |
ZIM Laboratories Limited | 812.62 Million INR | 94.86% |
Sakar Healthcare Limited | 277.32 Million INR | 84.938% |
Aurobindo Pharma Limited | 98.08 Billion INR | 99.957% |
Divi's Laboratories Limited | 31.84 Billion INR | 99.869% |
AstraZeneca Pharma India Limited | 2.27 Billion INR | 98.167% |
Mankind Pharma Limited | 15.53 Billion INR | 99.731% |
Sequent Scientific Limited | 3.46 Billion INR | 98.794% |
Neuland Laboratories Limited | 3.5 Billion INR | 98.808% |
J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 99.169% |
Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 99.834% |
Zydus Lifesciences Limited | 34.41 Billion INR | 99.879% |
Amrutanjan Health Care Limited | 289.04 Million INR | 85.549% |
Wockhardt Limited | 6.4 Billion INR | 99.347% |
Bal Pharma Limited | 878.11 Million INR | 95.243% |
Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.934% |
Bliss GVS Pharma Limited | 1.18 Billion INR | 96.474% |
Caplin Point Laboratories Limited | 3.63 Billion INR | 98.849% |
Shilpa Medicare Limited | 3.44 Billion INR | 98.789% |
Valiant Laboratories Limited | 100.15 Million INR | 58.294% |
Ajanta Pharma Limited | 8.28 Billion INR | 99.496% |
Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | 87.954% |
Granules India Limited | 13 Billion INR | 99.679% |
Medicamen Biotech Limited | 593.75 Million INR | 92.965% |
Syncom Formulations (India) Limited | 210.81 Million INR | 80.186% |
Piramal Enterprises Limited | - INR | -Infinity% |
Torrent Pharmaceuticals Limited | 22.79 Billion INR | 99.817% |
NATCO Pharma Limited | 7 Billion INR | 99.404% |
Suven Life Sciences Limited | 7.08 Million INR | -489.555% |
Krebs Biochemicals & Industries Limited | 97.96 Million INR | 57.362% |
Strides Pharma Science Limited | 11.26 Billion INR | 99.629% |
Indoco Remedies Limited | 3.53 Billion INR | 98.817% |
Alpa Laboratories Limited | 136.65 Million INR | 69.434% |
Lasa Supergenerics Limited | 190.43 Million INR | 78.066% |
Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -182.382% |